ELI LILLY & CO (LLY.DE) Stock Fundamental Analysis
Europe - Frankfurt Stock Exchange - FRA:LLY - US5324571083 - Common Stock
912.4 EUR
+6.2 (+0.68%)
Overall LLY gets a fundamental rating of 6 out of 10. We evaluated LLY against 52 industry peers in the Pharmaceuticals industry. LLY scores excellent on profitability, but there are some minor concerns on its financial health. LLY shows excellent growth, but is valued quite expensive already. These ratings would make LLY suitable for growth investing!
1. Profitability
1.1 Basic Checks
LLY had positive earnings in the past year.
LLY had a positive operating cash flow in the past year.
In the past 5 years LLY has always been profitable.
LLY had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
LLY's Return On Assets of 16.02% is amongst the best of the industry. LLY outperforms 90.74% of its industry peers.
LLY has a Return On Equity of 77.38%. This is amongst the best in the industry. LLY outperforms 96.30% of its industry peers.
LLY has a Return On Invested Capital of 28.84%. This is amongst the best in the industry. LLY outperforms 94.44% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for LLY is significantly above the industry average of 13.72%.
The last Return On Invested Capital (28.84%) for LLY is above the 3 year average (21.71%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 16.02% | ||
| ROE | 77.38% | ||
| ROIC | 28.84% |
ROA(3y)11.42%
ROA(5y)11.8%
ROE(3y)60.64%
ROE(5y)70.77%
ROIC(3y)21.71%
ROIC(5y)19.96%
1.3 Margins
LLY has a better Profit Margin (30.99%) than 96.30% of its industry peers.
LLY's Profit Margin has declined in the last couple of years.
The Operating Margin of LLY (44.41%) is better than 96.30% of its industry peers.
In the last couple of years the Operating Margin of LLY has grown nicely.
LLY has a better Gross Margin (83.03%) than 87.04% of its industry peers.
In the last couple of years the Gross Margin of LLY has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 44.41% | ||
| PM (TTM) | 30.99% | ||
| GM | 83.03% |
OM growth 3Y12.38%
OM growth 5Y7.84%
PM growth 3Y6.05%
PM growth 5Y-8.8%
GM growth 3Y3.11%
GM growth 5Y0.62%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), LLY is creating value.
The number of shares outstanding for LLY remains at a similar level compared to 1 year ago.
The number of shares outstanding for LLY has been reduced compared to 5 years ago.
The debt/assets ratio for LLY is higher compared to a year ago.
2.2 Solvency
LLY has an Altman-Z score of 8.47. This indicates that LLY is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of LLY (8.47) is better than 96.30% of its industry peers.
LLY has a debt to FCF ratio of 6.60. This is a slightly negative value and a sign of low solvency as LLY would need 6.60 years to pay back of all of its debts.
The Debt to FCF ratio of LLY (6.60) is worse than 61.11% of its industry peers.
A Debt/Equity ratio of 1.72 is on the high side and indicates that LLY has dependencies on debt financing.
LLY has a Debt to Equity ratio of 1.72. This is in the lower half of the industry: LLY underperforms 79.63% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.72 | ||
| Debt/FCF | 6.6 | ||
| Altman-Z | 8.47 |
ROIC/WACC3.12
WACC9.25%
2.3 Liquidity
A Current Ratio of 1.55 indicates that LLY should not have too much problems paying its short term obligations.
LLY has a better Current ratio (1.55) than 62.96% of its industry peers.
LLY has a Quick Ratio of 1.24. This is a normal value and indicates that LLY is financially healthy and should not expect problems in meeting its short term obligations.
LLY's Quick ratio of 1.24 is fine compared to the rest of the industry. LLY outperforms 72.22% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.55 | ||
| Quick Ratio | 1.24 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 116.22% over the past year.
The Earnings Per Share has been growing by 16.57% on average over the past years. This is quite good.
The Revenue has grown by 45.41% in the past year. This is a very strong growth!
LLY shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 15.08% yearly.
EPS 1Y (TTM)116.22%
EPS 3Y16.75%
EPS 5Y16.57%
EPS Q2Q%494.92%
Revenue 1Y (TTM)45.41%
Revenue growth 3Y16.73%
Revenue growth 5Y15.08%
Sales Q2Q%53.87%
3.2 Future
The Earnings Per Share is expected to grow by 31.53% on average over the next years. This is a very strong growth
LLY is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 18.88% yearly.
EPS Next Y84.97%
EPS Next 2Y58.86%
EPS Next 3Y46.26%
EPS Next 5Y31.53%
Revenue Next Year41.27%
Revenue Next 2Y30.36%
Revenue Next 3Y25.76%
Revenue Next 5Y18.88%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 48.90 indicates a quite expensive valuation of LLY.
Based on the Price/Earnings ratio, LLY is valued a bit more expensive than 64.81% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 26.92. LLY is valued rather expensively when compared to this.
The Price/Forward Earnings ratio is 32.78, which means the current valuation is very expensive for LLY.
Compared to the rest of the industry, the Price/Forward Earnings ratio of LLY indicates a slightly more expensive valuation: LLY is more expensive than 66.67% of the companies listed in the same industry.
LLY's Price/Forward Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 23.46.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 48.9 | ||
| Fwd PE | 32.78 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of LLY indicates a slightly more expensive valuation: LLY is more expensive than 72.22% of the companies listed in the same industry.
LLY's Price/Free Cash Flow ratio is a bit more expensive when compared to the industry. LLY is more expensive than 68.52% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 157.96 | ||
| EV/EBITDA | 37.09 |
4.3 Compensation for Growth
LLY's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
LLY has an outstanding profitability rating, which may justify a higher PE ratio.
LLY's earnings are expected to grow with 46.26% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.58
PEG (5Y)2.95
EPS Next 2Y58.86%
EPS Next 3Y46.26%
5. Dividend
5.1 Amount
With a yearly dividend of 0.64%, LLY is not a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 2.20, LLY has a dividend in line with its industry peers.
Compared to an average S&P500 Dividend Yield of 2.00, LLY's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.64% |
5.2 History
The dividend of LLY is nicely growing with an annual growth rate of 15.59%!
Dividend Growth(5Y)15.59%
Div Incr Years6
Div Non Decr Years6
5.3 Sustainability
28.28% of the earnings are spent on dividend by LLY. This is a low number and sustainable payout ratio.
LLY's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP28.28%
EPS Next 2Y58.86%
EPS Next 3Y46.26%
FRA:LLY (12/23/2025, 7:00:00 PM)
912.4
+6.2 (+0.68%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners83.08%
Inst Owner ChangeN/A
Ins Owners0.16%
Ins Owner ChangeN/A
Market Cap862.56B
Revenue(TTM)59.42B
Net Income(TTM)18.41B
Analysts80.54
Price Target940.38 (3.07%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.64% |
Yearly Dividend4.19
Dividend Growth(5Y)15.59%
DP28.28%
Div Incr Years6
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)18.28%
Min EPS beat(2)14.51%
Max EPS beat(2)22.05%
EPS beat(4)4
Avg EPS beat(4)13.1%
Min EPS beat(4)6.45%
Max EPS beat(4)22.05%
EPS beat(8)7
Avg EPS beat(8)12.06%
EPS beat(12)10
Avg EPS beat(12)23.73%
EPS beat(16)13
Avg EPS beat(16)17.41%
Revenue beat(2)2
Avg Revenue beat(2)6.77%
Min Revenue beat(2)4.72%
Max Revenue beat(2)8.81%
Revenue beat(4)2
Avg Revenue beat(4)2.95%
Min Revenue beat(4)-1.24%
Max Revenue beat(4)8.81%
Revenue beat(8)4
Avg Revenue beat(8)2.39%
Revenue beat(12)7
Avg Revenue beat(12)2.64%
Revenue beat(16)9
Avg Revenue beat(16)2.04%
PT rev (1m)6.76%
PT rev (3m)22.14%
EPS NQ rev (1m)0.15%
EPS NQ rev (3m)3.74%
EPS NY rev (1m)2.25%
EPS NY rev (3m)4.78%
Revenue NQ rev (1m)0.46%
Revenue NQ rev (3m)2.96%
Revenue NY rev (1m)1.87%
Revenue NY rev (3m)3.3%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 48.9 | ||
| Fwd PE | 32.78 | ||
| P/S | 17.11 | ||
| P/FCF | 157.96 | ||
| P/OCF | 63.3 | ||
| P/B | 42.73 | ||
| P/tB | 88.81 | ||
| EV/EBITDA | 37.09 |
EPS(TTM)18.66
EY2.05%
EPS(NY)27.83
Fwd EY3.05%
FCF(TTM)5.78
FCFY0.63%
OCF(TTM)14.41
OCFY1.58%
SpS53.32
BVpS21.35
TBVpS10.27
PEG (NY)0.58
PEG (5Y)2.95
Graham Number94.68
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 16.02% | ||
| ROE | 77.38% | ||
| ROCE | 35.28% | ||
| ROIC | 28.84% | ||
| ROICexc | 33.25% | ||
| ROICexgc | 41.06% | ||
| OM | 44.41% | ||
| PM (TTM) | 30.99% | ||
| GM | 83.03% | ||
| FCFM | 10.83% |
ROA(3y)11.42%
ROA(5y)11.8%
ROE(3y)60.64%
ROE(5y)70.77%
ROIC(3y)21.71%
ROIC(5y)19.96%
ROICexc(3y)23.23%
ROICexc(5y)21.74%
ROICexgc(3y)32.89%
ROICexgc(5y)32.31%
ROCE(3y)29.19%
ROCE(5y)26%
ROICexgc growth 3Y1.59%
ROICexgc growth 5Y4.02%
ROICexc growth 3Y9.55%
ROICexc growth 5Y8.82%
OM growth 3Y12.38%
OM growth 5Y7.84%
PM growth 3Y6.05%
PM growth 5Y-8.8%
GM growth 3Y3.11%
GM growth 5Y0.62%
F-Score7
Asset Turnover0.52
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.72 | ||
| Debt/FCF | 6.6 | ||
| Debt/EBITDA | 1.44 | ||
| Cap/Depr | 507.66% | ||
| Cap/Sales | 16.2% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 56.78% | ||
| Profit Quality | 34.96% | ||
| Current Ratio | 1.55 | ||
| Quick Ratio | 1.24 | ||
| Altman-Z | 8.47 |
F-Score7
WACC9.25%
ROIC/WACC3.12
Cap/Depr(3y)385.26%
Cap/Depr(5y)286.02%
Cap/Sales(3y)16.93%
Cap/Sales(5y)13.13%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)116.22%
EPS 3Y16.75%
EPS 5Y16.57%
EPS Q2Q%494.92%
EPS Next Y84.97%
EPS Next 2Y58.86%
EPS Next 3Y46.26%
EPS Next 5Y31.53%
Revenue 1Y (TTM)45.41%
Revenue growth 3Y16.73%
Revenue growth 5Y15.08%
Sales Q2Q%53.87%
Revenue Next Year41.27%
Revenue Next 2Y30.36%
Revenue Next 3Y25.76%
Revenue Next 5Y18.88%
EBIT growth 1Y82.81%
EBIT growth 3Y31.18%
EBIT growth 5Y24.1%
EBIT Next Year101.98%
EBIT Next 3Y46.72%
EBIT Next 5Y32.15%
FCF growth 1Y4003.21%
FCF growth 3Y-57.48%
FCF growth 5Y-34.68%
OCF growth 1Y158.46%
OCF growth 3Y6.69%
OCF growth 5Y12.76%
ELI LILLY & CO / LLY.DE FAQ
What is the fundamental rating for LLY stock?
ChartMill assigns a fundamental rating of 6 / 10 to LLY.DE.
What is the valuation status for LLY stock?
ChartMill assigns a valuation rating of 3 / 10 to ELI LILLY & CO (LLY.DE). This can be considered as Overvalued.
What is the profitability of LLY stock?
ELI LILLY & CO (LLY.DE) has a profitability rating of 9 / 10.
What is the financial health of ELI LILLY & CO (LLY.DE) stock?
The financial health rating of ELI LILLY & CO (LLY.DE) is 5 / 10.
What is the expected EPS growth for ELI LILLY & CO (LLY.DE) stock?
The Earnings per Share (EPS) of ELI LILLY & CO (LLY.DE) is expected to grow by 84.97% in the next year.